Catalyst Wire Dossier Catalyst Wire Dossier

QAW039

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for QAW039, covering 2013-10-09 to 2021-05-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment. [Phase 3]

See pricing